Old Web
English
Sign In
Acemap
>
authorDetail
>
Rachel Soon
Rachel Soon
Novartis
Medicine
Pharmacokinetics
Midazolam
Psoriasis
Secukinumab
3
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety, pharmacokinetics and causal prophylactic efficacy of KAF156 in a Plasmodium falciparum human infection study.
2020
Clinical Infectious Diseases
James G. Kublin
Sean C. Murphy
Janine Maenza
Annette M. Seilie
Jay Prakash Jain
David Berger
Danielle Spera
Rong Zhao
Rachel Soon
Julie L Czartoski
Meredith A Potochnic
Elizabeth R Duke
Ming Chang
Ashley M. Vaughan
Stefan H. I. Kappe
F. Joel Leong
Peter Pertel
William T Prince
Show All
Source
Cite
Save
Citations (1)
Secukinumab treatment does not alter the pharmacokinetics of the CYP3A4 substrate midazolam in patients with moderate to severe psoriasis – results from an open label disease-drug-drug interaction study
2019
Gerardus Bruin
Anke Hasselberg
Irena Korolova
Julie Milojevic
Claudio Calonder
Rachel Soon
Ralph Woessner
David M. Pariser
Bruno Boutouyrie-Dumont
Show All
Source
Cite
Save
Citations (0)
Secukinumab treatment does not alter the pharmacokinetics of the CYP3A4 substrate midazolam in patients with moderate to severe psoriasis
2019
Clinical Pharmacology & Therapeutics
Gerard Bruin
Anke Hasselberg
Irina Koroleva
Julie Milojevic
Claudio Calonder
Rachel Soon
Ralph Woessner
David M. Pariser
Bruno Boutouyrie-Dumont
Show All
Source
Cite
Save
Citations (5)
1